Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...
NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described as “devastating”. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback